The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-4-((S)-2-((S)-3-(1H-indol-3-yl)-2-(2-(5-methyl-1H-indol-2-yl)acetamido)propanamido)-4-ethoxy-4-oxobutanamido)-5-methoxy-5-oxopentanoic acid ID: ALA5267289
Max Phase: Preclinical
Molecular Formula: C34H39N5O9
Molecular Weight: 661.71
Associated Items:
Names and Identifiers Canonical SMILES: CCOC(=O)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)Cc1cc2cc(C)ccc2[nH]1)C(=O)N[C@@H](CCC(=O)O)C(=O)OC
Standard InChI: InChI=1S/C34H39N5O9/c1-4-48-31(43)17-28(33(45)38-26(34(46)47-3)11-12-30(41)42)39-32(44)27(15-21-18-35-25-8-6-5-7-23(21)25)37-29(40)16-22-14-20-13-19(2)9-10-24(20)36-22/h5-10,13-14,18,26-28,35-36H,4,11-12,15-17H2,1-3H3,(H,37,40)(H,38,45)(H,39,44)(H,41,42)/t26-,27-,28-/m0/s1
Standard InChI Key: YDTMYUKQNSCCOD-KCHLEUMXSA-N
Molfile:
RDKit 2D
48 51 0 0 0 0 0 0 0 0999 V2000
-6.2606 -0.3341 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.5461 0.0783 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.8315 -0.3342 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.1169 0.0783 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.1169 0.9035 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.8315 1.3161 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.8315 2.1413 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.5461 2.5539 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.1169 2.5539 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.4022 -0.3342 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.6876 0.0783 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9729 -0.3342 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2582 0.0783 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.5436 -0.3342 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1709 0.0783 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1709 0.9035 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5436 1.3161 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2582 0.9035 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8770 1.4748 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.5463 2.2094 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7221 2.1171 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2282 2.7876 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5647 3.5450 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3849 3.6351 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8769 2.9672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8856 -0.3342 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.6003 0.0783 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3149 -0.3342 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0296 0.0783 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0296 0.9035 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.8337 1.1536 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3045 0.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8125 -0.1675 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1094 0.5814 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4354 1.3175 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9655 1.9668 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1639 1.8857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2606 1.3175 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6003 0.9035 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.5436 -1.1594 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.9729 -1.1594 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6876 -1.5721 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6876 -2.3972 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.9729 -2.8098 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9729 -3.6351 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4022 -1.1594 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.6876 0.9035 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.8315 -1.1594 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 6
5 6 1 0
6 7 1 0
7 8 2 0
7 9 1 0
4 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 6
16 17 1 0
18 17 2 0
18 19 1 0
19 20 1 0
21 20 2 0
17 21 1 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
20 25 1 0
15 26 1 0
26 27 1 0
27 28 1 0
28 29 1 0
30 29 1 0
30 31 1 0
31 32 2 0
33 32 1 0
29 33 2 0
32 34 1 0
34 35 2 0
35 36 1 0
36 37 2 0
31 37 1 0
35 38 1 0
27 39 2 0
14 40 2 0
12 41 1 1
41 42 1 0
42 43 1 0
43 44 1 0
44 45 1 0
42 46 2 0
11 47 2 0
3 48 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 661.71Molecular Weight (Monoisotopic): 661.2748AlogP: 2.19#Rotatable Bonds: 16Polar Surface Area: 208.78Molecular Species: ACIDHBA: 8HBD: 6#RO5 Violations: 2HBA (Lipinski): 14HBD (Lipinski): 6#RO5 Violations (Lipinski): 3CX Acidic pKa: 3.76CX Basic pKa: ┄CX LogP: 1.94CX LogD: -1.34Aromatic Rings: 4Heavy Atoms: 48QED Weighted: 0.10Np Likeness Score: -0.20
References 1. Phull MS, Jadav SS, Gundla R, Mainkar PS.. (2021) A perspective on medicinal chemistry approaches towards adenomatous polyposis coli and Wnt signal based colorectal cancer inhibitors., 212 [PMID:33445154 ] [10.1016/j.ejmech.2020.113149 ]